🔎 Trials Near Me

Почетна › Карцином на панкреасот › Мичиген

Клинички испитувања за Карцином на панкреасот во Мичиген

38 студии за Карцином на панкреасот бараат учесници на локации во Мичиген.

Градови во Мичиген

Официјален текст на студијата (англиски)

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Henry Ford Cancer Institute-Downriver, Brownstown
  • Henry Ford Health Center - Brownstown, Brownstown
  • Henry Ford Health Center - Chesterfield, Chesterfield
  • и уште 13
Се регрутираДобредојдени се здрави волонтери
Возраст од 45 до 75 · Сите полови · Ажурирано 5.10.2026 · NCT06995898

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06465069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Profound Research -OMG - TriAtria Cancer Center, Farmington Hills
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06760819

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

  • McLaren Proton Therapy Center, Flint
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT02598349

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US006, Ann Arbor
  • Investigative Site US010, Detroit
  • Investigative Site US078, Grand Rapids
  • и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07522073

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

  • University of Michigan Health - University of Michigan Medical Center, Ann Arbor
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07409272

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • START Midwest, Grand Rapids
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • University of Michigan Medical School Rogel Cancer Center, Ann Arbor
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT07629960

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  • START Midwest, Grand Rapids
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT07349537

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0119, Ann Arbor
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07492680

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

  • MyMichigan Medical Center Gratiot, Alma
  • MyMichigan Medical Center Alpena, Alpena
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • и уште 61
Се регрутираНабљудувачка студија
Возраст од 50 до 75 · Сите полови · Ажурирано 4.9.2026 · NCT04239573

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT06400472

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  • University of Michigan, Ann Arbor
  • START Midwest, Grand Rapids
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07644559

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

  • Karmanos Cancer Institute, Detroit
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT06673017

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  • The Cancer & Hematology Centers, Grand Rapids
  • Cancer and Hematology Centers of Western Michigan, Norton Shores
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT05245500

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
  • и уште 27
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT06958328

A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.

  • Karmanos Cancer Institute, Detroit
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT07157033

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START Midwest, Grand Rapids
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 11.8.2026 · NCT06242470

Pancreatic Cancer Early Detection Consortium

  • University of Michigan, Ann Arbor
  • Beaumont/Corewell Health, Royal Oak
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 18 до 90 · Сите полови · Ажурирано 22.7.2026 · NCT04970056

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

  • Karmanos Cancer Center, Detroit
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 15.7.2026 · NCT06937177

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

  • University of Michigan Health, Ann Arbor
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 6.7.2026 · NCT07481383

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

  • BAMF Health, Grand Rapids
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 17.6.2026 · NCT07219238

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

  • Bronson Battle Creek, Battle Creek
  • OSF Saint Francis Hospital and Medical Group, Escanaba
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • и уште 14
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.5.2026 · NCT06998940

A Study of MGC028 in Participants With Advanced Solid Tumors

  • South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 27.4.2026 · NCT06723236

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • University of Michigan, Ann Arbor
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.4.2026 · NCT07020221

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

  • Henry Ford Centre, Detroit
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 3.4.2026 · NCT06850623

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

  • Karmanos Cancer Institute, Detroit
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 18.3.2026 · NCT06244771

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

  • START Midwest, Grand Rapids
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 18.2.2026 · NCT07030257

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University-Telemedicine, Ann Arbor
  • Ohio State University-Telemedicine, Detroit
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 17.2.2026 · NCT06906562

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

  • START, Midwest, Grand Rapids
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.2.2026 · NCT07145255

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Trinity Health Grand Rapids Hospital, Grand Rapids
  • Dickinson County Healthcare System, Iron Mountain
  • и уште 2
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 9.1.2026 · NCT06073431

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

  • Henry Ford Cancer-Detroit, Detroit
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 19.12.2025 · NCT06065371

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Ann Arbor
  • Massive Bio SYNERGY-AI site, Lansing
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

The Cancer of the Pancreas Screening-5 CAPS5)Study

  • University of Michigan, Ann Arbor
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 9.10.2025 · NCT02000089

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

  • University of Michigan, Ann Arbor
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2025 · NCT05941507

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

  • BAMF Health, Inc., Grand Rapids
Се регрутираФаза 1/2
Возраст 15 и постари · Сите полови · Ажурирано 12.8.2025 · NCT06298916

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

  • Henry Ford Health System, Detroit
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 6.11.2024 · NCT05254171

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.